A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...

In 2022, Arizona was one of the first states in the nation to pass legislation (House Bill 2144) requiring Medicaid and commercial insurance plans to cover qualified biomarker tes ...

My ideal client is someone who’s ready to begin the journey toward better mental well-being — whether they’re feeling anxious, struggling to focus, or weighed down by depression or life’s transitions.

Offering Genesite genetic medication testing, ADHD computer testing (QB Test- neuropsych FDA cleared testing) and much more! NO Benzodiazepines (786) 933-6711View(786) 933-6711 Dr. Sanaz Parsa ...

Four out of five adults in Florida who need addiction treatment go without care. The Haven Detox - Florida urges people ...

Good day and thank you for standing by. Welcome to the Myriad Genetics Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported in Q4 CY2025, but sales were flat year on year at $209.8 million. The company expects the full year’s revenue to be around $870 million, ...

Q4 2025 Management View Samraat Raha, President and CEO, emphasized progress in high-growth market segments, citing "fourth quarter revenue of $210 million, coming in above the high end of the ...

Drivers of fourth quarter 2025 test volume growth year-over-year include Prolaris prostate cancer test at 12%, Hereditary cancer testing at 9%, and GeneSight at 9%. Fourth quarter 2025 gross margin ...

During National Cancer Prevention Month, a Los Angeles man explains why genetic testing for BRCA and other mutations matters for men and how action saves lives. Cunaplus_M.Faba Getty Images For most ...